Table 3.
Multivariable Analysis of Relationships between Baseline Characteristics and Transition
| Predictor | Levels | Transition | OR | 95% CI | P-value | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
| TRAQ domain 1 score | One unit increase | 3.22 ± 0.97 | 3.03 ± 0.83 | 1.28 | 0.79–2.10 | 0.32 |
| TRAQ domain 2 score | One unit increase | 3.90 ± 0.53 | 3.65 ± 0.86 | 1.67 | 0.85–3.27 | 0.14 |
| Age (years) | One unit increase | 18.77 ± 1.65 | 17.98 ± 1.49 | 1.39 | 1.04–1.86 | 0.03 |
| Disease duration (years) | One unit increase | 5.21 ± 3.85 | 4.50 ± 4.04 | 1.05 | 0.94–1.17 | 0.42 |
| Gender | Female (N = 56) | 25 (45%) | 31 (55%) | 0.75 | 0.30–1.88 | 0.54 |
| Male (N = 27) | 14 (52%) | 13 (48%) | 1.0 | |||
| Race | White (N = 68) | 31 (46%) | 37 (54%) | 0.73 | 0.24–2.25 | 0.59 |
| Non-white (N = 15) | 8 (53%) | 7 (47%) | 1.0 | |||
| Insurance type | Private (N = 58) | 29 (50%) | 29 (50%) | 1.5 | 0.53–4.21 | 0.44 |
| Public (N = 20) | 8 (40%) | 12 (60%) | 1.0 | |||
| Specialty | Endocrinology (N = 18) | 8 (44%) | 10 (56%) | 1.18 | 0.39–3.53 | 0.16 |
| Gastroenterology (N = 18) | 12 (67%) | 6 (33%) | 2.95 | 0.94–9.22 | ||
| Rheumatology (N = 47) | 19 (40%) | 28 (60%) | 1.0 | |||
| Have seen provider independently | Sometimes/Often/Always (N = 42) | 23 (55%) | 19 (45%) | 1.74 | 0.72–4.20 | 0.22 |
| Never/Rarely (N = 39) | 16 (41%) | 23 (59%) | 1.0 | |||
| Have discussed transition with provider | Yes (N = 34) | 21 (62%) | 13 (38%) | 2.42 | 0.97–6.04 | 0.06 |
| No (N = 45) | 18 (40%) | 27 (60%) | 1.0 | |||
Abbreviations: TRAQ Transition Readiness Assessment Questionnaire